Biomarker Testing for People With Advanced Lung Cancer in England

Biomarker Testing for People With Advanced Lung Cancer in England

Introduction: Optimal management of people with advanced NSCLC depends on accurate identification of predictive markers. Yet, real-world data in this setting are limited. We describe the impact, timeliness, and outcomes of molecular testing for patients with advanced NSCLC and good performance statu...

Full description

Bibliographic Details
Main Authors: Jana B. Adizie, MbChB., MRCP, MD, Judith Tweedie, MD, Aamir Khakwani, PhD, Emily Peach, PhD, Richard Hubbard, PhD, Natasha Wood, BSc, John R. Gosney, MD, Susan V. Harden, DM(Oxon), Paul Beckett, MD, Sanjay Popat, PhD, Neal Navani, MA, MSc, PhD, FRCP
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:JTO Clinical and Research Reports
Subjects:
Non–small cell lung cancer
Mutation testing
Biomarkers
Targeted therapy
Personalized medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364321000357

Internet

http://www.sciencedirect.com/science/article/pii/S2666364321000357

Similar Items